Pharmacie de Lauzelle SPRL
Pharmacie de Lauzelle reported total assets of 187,112 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of Pharmacie de Lauzelle shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie de Lauzelle's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 14 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Pharmacie de Lauzelle's financial analysis
- Solvency99.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie de Lauzelle
Pharmacie de Lauzelle's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0466.774.391
- VAT number
- BE0466774391
- Peppol
- Registered · 0208:0466774391 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 09 Sep 1999
- Registered office
- 1348 Ottignies-Louvain-la-Neuve
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie de Lauzelle (SPRL) has been based in Ottignies-Louvain-la-Neuve since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 154 € and equity of 185,359 €; its revenue is not published. Its solvency stands at 99.1%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie de Lauzelle
Companies in the same business, of comparable size and area, outside its group.
- Panadem Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 188,078 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Apotheek Synaps Park Retail sale of pharmaceutical products Genk · balance sheet 189,539 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
- Emilie Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,476 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
- Heyde Pharma Retail sale of pharmaceutical products Jabbeke · balance sheet 192,810 €
- Hilde Braeken Retail sale of pharmaceutical products Hasselt · balance sheet 180,493 €
Frequently asked questions about Pharmacie de Lauzelle
What is the revenue of Pharmacie de Lauzelle?
Pharmacie de Lauzelle files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie de Lauzelle?
In Belgium, the VAT number is the company number prefixed with BE: BE0466774391 for Pharmacie de Lauzelle, if the company is VAT-registered. Its company number (CBE) is 0466.774.391.
Where is the registered office of Pharmacie de Lauzelle?
According to the CBE register, the registered office of Pharmacie de Lauzelle is in 1348 Ottignies-Louvain-la-Neuve.
What is the equity of Pharmacie de Lauzelle?
At the close of the 2025 financial year, the equity of Pharmacie de Lauzelle amounts to 185,359 €, a solvency of 99.1% of total assets.
Who manages Pharmacie de Lauzelle?
The register lists 1 active mandates at Pharmacie de Lauzelle. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie de Lauzelle
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →